Table 6 County trends (P < 0.01) by state in seroprevalence of antibodies to Anaplasma phagocytophilum
State (n)a | Counties with decreasing trend n (%) | Counties with increasing trend n (%) | Counties with no change n (%) |
|---|---|---|---|
Majority counties decreasing | |||
Connecticut (n = 8) | 6 (75.0) | 0 (0.0) | 2 (25.0) |
New Jersey (n = 21) | 12 (57.1) | 2 (9.5) | 7 (33.3) |
Wisconsin (n = 58) | 29 (50.0) | 6 (10.3) | 23 (39.6) |
Majority counties increasing | |||
Massachusetts (n = 14) | 3 (21.4) | 8 (57.1) | 3 (21.4) |
Maine (n = 16) | 1 (6.2) | 14 (87.5) | 1 (6.2) |
New Hampshire (n = 10) | 0 (0.0) | 9 (90.0) | 1 (10.0) |
Pennsylvania (n = 61) | 1 (1.6) | 47 (77.0) | 13 (21.3) |
Vermont (n = 11) | 0 (0.0) | 9 (81.8) | 2 (18.2) |
Mixed county trends | |||
Delaware (n = 3) | 0 (0.0) | 0 (0.0) | 3 (100) |
Iowa (n = 42) | 5 (11.9) | 3 (7.1) | 34 (80.9) |
Illinois (n = 50) | 9 (18.0) | 0 (0.0) | 41 (82.0) |
Indiana (n = 48) | 4 (8.3) | 1 (2.0) | 43 (89.5) |
Kentucky (n = 41) | 2 (4.9) | 2 (4.9) | 37 (90.2) |
Maryland (n = 23) | 6 (26.1) | 1 (4.3) | 16 (69.6) |
Michigan (n = 60) | 7 (11.7) | 4 (6.7) | 49 (81.7) |
Minnesota (n = 47) | 23 (48.9) | 3 (6.4) | 21 (44.7) |
North Carolina (n = 69) | 12 (17.4) | 1 (1.4) | 56 (81.1) |
North Dakota (n = 8) | 0 (0.0) | 0 (0.0) | 8 (100) |
New York (n = 60) | 6 (10.0) | 29 (48.3) | 25 (41.7) |
Ohio (n = 58) | 7 (12.1) | 3 (5.1) | 48 (82.7) |
Rhode Island (n = 5) | 2 (40.0) | 1 (20.0) | 2 (40.0) |
South Carolina (n = 22) | 3 (13.6) | 0 (0.0) | 19 (86.4) |
Tennessee (n = 36) | 2 (5.5) | 1 (2.8) | 33 (91.7) |
Virginia (n = 85) | 24 (28.2) | 5 (5.9) | 56 (65.9) |
West Virginia (n = 31) | 3 (9.6) | 8 (25.8) | 20 (64.5) |